Earlier this year, an FDA trial began for a potential glaucoma treatment that aims to return damaged optic nerves to a more youthful state. It could be the latest step in the race to redefine how our bodies age. D.T. Max explores more: on.natgeo.com/dz1mPX
Thread
Nenhum Voo ainda